Add office photos
Engaged Employer
Abbott
4.1
based on 3.1k Reviews
Video summary
Proud winner of ABECA 2024 - AmbitionBox Employee Choice Awards
Company Overview
Associated Companies
Company Locations
Working at Abbott
Company Summary
Abbott's life-changing technology helps people live fully and offers information, medicines and breakthroughs to help manage people's health.
Overall Rating
4.1/5
based on 3.1k reviews
5% above
industry average
Highly rated for
Company culture, Salary, Work-life balance
Critically rated for
Promotions
Work Policy
Work from office
52% employees reported
Monday to Saturday
48% employees reported
Flexible timing
71% employees reported
Within city
45% employees reported
View detailed work policy
Top Employees Benefits
Job/Soft skill training
268 employees reported
Health insurance
250 employees reported
Office cab/shuttle
93 employees reported
Professional degree assistance
89 employees reported
View all benefits
About Abbott
Founded in1888 (137 yrs old)
India Employee Count1k-5k
Global Employee Count10k-50k
India HeadquartersMumbai, Maharashtra, India
Websiteabbott.com
Primary Industry
Other Industries
View in video summary
CREATING LIFE-CHANGING TECHNOLOGY
At Abbott, we’re dedicated to helping people live more fully, in everything we do. We’re creating the future of healthcare through life-changing technologies and products that make you healthier and stronger, quickly identify when you have a medical need, and treat conditions to help you get back to doing what you love.
With headquarters in north suburban Chicago, we serve people in more than 160 countries with leading medical devices, diagnostics, nutrition products, and branded generic medicines. Our 114,000 colleagues are helping millions of people to live better and healthier, every day around the world.
Mission: Live your best life, now and in the future
We understand that the first step to living your best life is good health. Everything we make is designed to help you do just that. That’s our commitment to building life-changing technologies that keep your heart healthy, nourish your body at every stage of life, help you feel and move better, and bring you information, medicines and breakthroughs to manage your health.
Vision: Let’s keep exploring how to push past those barriers that keep us from living our best, healthiest lives.
Brands of Abbott Healthcare
Medicine
3.6
• 22 reviews
AmbitionBox Best Places to Work in India Awards
Best of the best, rated by employees
Abbott won India’s Largest Employee Choice Awards in Large Companies Category.
#3 Top Rated Pharma Company
Share
Abbott Ratings
based on 3.1k reviews
Overall Rating
4.1/5
How AmbitionBox ratings work?
5
1.7k
4
795
3
321
2
141
1
187
Category Ratings
4.0
Company culture
4.0
Salary
4.0
Work-life balance
4.0
Skill development
3.8
Job security
3.8
Work satisfaction
3.3
Promotions
Abbott is rated 4.1 out of 5 stars on AmbitionBox, based on 3.1k company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Abbott
based on 2.9k reviews
4.0
Rated by 394 Women
Rated 4.0 for Company culture and 3.9 for Work-life balance
4.1
Rated by 2.5k Men
Rated 4.0 for Work-life balance and 4.0 for Company culture
Work Policy at Abbott
based on 342 reviews in last 6 months
Work from office
52%
Hybrid
40%
Permanent work from home
8%
Abbott Reviews
Top mentions in Abbott Reviews
+ 5 more
Compare Abbott with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | 4.1/5 based on 3.1k reviews | 3.9/5 based on 3.4k reviews | 4.4/5 based on 2k reviews | 4.2/5 based on 3.2k reviews |
Highly Rated for | Skill development Work-life balance Salary | Job security | Job security Skill development Company culture | Salary Job security Work-life balance |
Critically Rated for | Promotions | Promotions | No critically rated category | No critically rated category |
Primary Work Policy | Work from office 52% employees reported | Work from office 92% employees reported | Work from office 94% employees reported | Work from office 78% employees reported |
Rating by Women Employees | 4.0 Good rated by 394 women | 4.0 Good rated by 356 women | 4.5 Good rated by 323 women | 4.1 Good rated by 321 women |
Rating by Men Employees | 4.1 Good rated by 2.5k men | 3.8 Good rated by 2.9k men | 4.3 Good rated by 1.6k men | 4.2 Good rated by 2.7k men |
Job security | 3.8 Good | 4.0 Good | 4.4 Good | 4.1 Good |
View more
Abbott Salaries
Abbott salaries have received with an average score of 4.0 out of 5 by 3.1k employees.
Territory Business Manager
(872 salaries)
Unlock
₹1.7 L/yr - ₹9.3 L/yr
Area Business Manager
(475 salaries)
Unlock
₹6 L/yr - ₹20 L/yr
Therapy Business Manager
(433 salaries)
Unlock
₹3 L/yr - ₹10 L/yr
Key Account Manager
(383 salaries)
Unlock
₹3 L/yr - ₹13.5 L/yr
Territory Sales Manager
(255 salaries)
Unlock
₹2.9 L/yr - ₹12.6 L/yr
Medical Representative
(202 salaries)
Unlock
₹1.5 L/yr - ₹8.5 L/yr
Area Sales Manager
(165 salaries)
Unlock
₹6 L/yr - ₹26.7 L/yr
Sales Development Manager
(111 salaries)
Unlock
₹4.9 L/yr - ₹16.3 L/yr
Zonal Business Manager
(93 salaries)
Unlock
₹11.5 L/yr - ₹30.4 L/yr
Senior Territory Sales Executive
(81 salaries)
Unlock
₹6 L/yr - ₹15 L/yr
Abbott Interview Questions
Interview questions by designation
Top Abbott interview questions and answers
Get interview-ready with top interview questions
Abbott Jobs
Popular Designations Abbott Hires for
Current Openings
Abbott News
View all
Kotak Alternate invests in nutraceuticals CDMO Tirupati Medicare
- Kotak Alternate has invested in nutraceuticals contract development and manufacturing organization (CDMO) Tirupati Medicare.
- The investment supports Tirupati's expansion plans and facilitates a complete exit of the existing investor Affirma Capital.
- Tirupati is the largest player in the Indian nutraceutical CDMO space, catering to companies such as Herbalife, Abbott, and Glanbia.
- The investment will assist Tirupati in preparing for an IPO and exploring growth opportunities, including inorganic growth.
HinduBusinessLine | 26 Mar, 2025
Six Stocks That Made Significant MovesV
- Ulta Beauty (ULTA) rose by 13.68% on strong stock buyback program despite weak earnings.
- Microstrategy (MSTR) gained 13% as it continues to trade in a downtrend amidst rising bitcoin (BTC-USD) price.
- Crown Castle (CCI) surged 10.4% on better-than-expected fund flows and revenue.
- Abbott (ABT) slumped after a judge ordered a new trial in a baby formula-related case, closing below $140.
Baystreet | 17 Mar, 2025
Stocks To Buy: Abbott India, Bajaj Finance, Bharat Forge, Chambal Fertilizers
- Analysts have buy calls on Abbott India, Bajaj Finance, Bharat Forge, and Chambal Fertilizers.
- Aditya Agarwal suggests a 'buy' for Abbott India with a target price of Rs 31,700 apiece.
- Aditya Agarwala has a buy call on Bajaj Finance with a target price of Rs 9,000.
- Reliance Securities' Vikas Jain recommends a 'buy' for Bharat Forge with a target price of Rs 1,170 apiece.
Bloomberg Quint | 27 Feb, 2025
Optimus’ Linezolid Patent Revoked After Post-Grant Opposition
- The Indian Patent Office has revoked Patent No. 281489 held by Optimus after a post-grant opposition by Symed Labs.
- The patent was revoked due to lacking obviousness/inventive step and not being a patentable invention under section 3(d) and section 8 of the Patents Act.
- Linezolid, the subject of the patent, is an antibiotic used against pneumonia, skin infections, and drug-resistant tuberculosis.
- The drug is part of the National Pharmaceutical Pricing Authority's list with a fixed price, followed by a challenge by Abbott Healthcare, rejected in October 2024.
- The post-grant opposition process had several rounds of back and forth before a hearing took place in June 2024.
- Grounds for opposition included anticipation by prior publication, anticipation by prior claiming, obviousness, lack of inventive step, and not being a new invention.
- The patent office found that the claims were not anticipated by prior publication or claiming, but lacked inventive step and did not represent a new invention.
- The decision questioned the level of scrutiny by the patent office on procedural requirements like disclosure under section 8.
- The analysis focused on grounds like obviousness and non-patentability under section 3(d), highlighting the need for stringent examination in pharmaceutical patents.
- The opponent in the case, Symed Labs, had a history of litigating against patents related to Linezolid and specific infringement claims in the past.
Spicyip | 24 Feb, 2025
RP Sanjiv Goenka Group elevates Janesh K to VP-group corporate HR
- RP Sanjiv Goenka Group has elevated Janesh K to the role of VP-group corporate HR.
- Janesh K moves from RP-SG FMCG (Guiltfree Industries) where he was CHRO since 2020.
- In his new role, Janesh will spearhead HR excellence initiatives and contribute to strategic HR programs.
- He will be based out of Kolkata.
HRKatha | 28 Jan, 2025
A secretary turned $180 into $7.2 million by holding her employer's stock for 75 years
- Grace Groner, a secretary, bought three shares of her employer's stock for $60 in 1935.
- By reinvesting dividends for 75 years, her stake grew to $7.2 million.
- Groner gifted her entire fortune to a foundation supporting her alma mater.
- She maintained her modest lifestyle, living in a one-bedroom house and buying clothes from rummage sales.
Insider | 22 Dec, 2024
From Abbott India, PVR Inox To Gujarat Gas And More: NSE To Exclude 16 Securities From F&O Effective Feb. 28
- The National Stock Exchange of India will exclude 16 securities, including Abbott India Ltd., PVR Inox Ltd., and Gujarat Gas Ltd., from the F&O market, effective Feb. 28, 2025.
- This exclusion is a result of revised guidelines from SEBI to increase liquidity standards.
- Existing unexpired contracts of the excluded securities will continue to be available for trading till their respective expiry.
- The updated criteria include higher thresholds for metrics such as median quarter sigma order size (MQSOS), minimum market-wide position limit (MWPL), and minimum average daily delivery value.
Bloomberg Quint | 20 Dec, 2024
Trading Ideas: Don't Buy Axis Bank, NCC At Current Levels, Say Stock Market Experts
- Stock market experts advise against buying Axis Bank and NCC at current levels.
- Kushal Gandhi suggests avoiding Axis Bank as it has been on a downtrend with selling pressure sustaining.
- Sameer Dalal recommends buying NCC at lower levels, expecting a decent return over the next two years.
- Dalal advises investors to switch from Abbott India to Dr Reddy's Laboratories due to the latter's larger growth opportunity.
Bloomberg Quint | 20 Dec, 2024
Abbott India Q2 Results: Profit Rises 15%, Beating Estimates
- Abbott India reported a net profit of Rs 359 crore, beating the consensus estimate of Rs 237 crore.
- Revenue increased by 9% to Rs 1,633 crore compared to the Bloomberg estimate of Rs 1,627 crore.
- Ebitda rose 15% to Rs 439 crore with a margin of 26.9%.
- Shares of Abbott India were trading 2.25% lower.
Bloomberg Quint | 7 Nov, 2024
British house price growth slows more than expected; UK borrowing costs close to annual high after budget – business live
- British house price growth slows more than expected.
- UK borrowing costs close to annual high after budget.
- Reckitt Benckiser's shares surge 10% following a US court ruling on its baby formula subsidiary, Mead Johnson.
- Abbott and Reckitt unit Mead Johnson found not responsible for a young boy's intestinal disease in a lawsuit victory.
Guardian | 1 Nov, 2024
Powered by
Abbott Subsidiaries
Abbott Diabetes Care
3.7
• 34 reviews
Abbott Vascular
4.5
• 15 reviews
St. Jude Medical
2.8
• 12 reviews
Abbott Point of Care
4.2
• 4 reviews
Inverness Medical Innovations
1.0
• 1 review
Report error
Compare Abbott with
GlaxoSmithKline Pharmaceuticals
4.1
Pfizer
4.0
DIVI'S Laboratories
3.7
Sanofi
4.2
Fresenius Kabi
4.2
Piramal Pharma
4.0
Novo Nordisk
4.1
Teva Pharmaceuticals
3.9
AstraZeneca
4.1
Eli Lilly and Company
3.8
Sandoz
3.9
Par Pharmaceutical Companies
4.3
Novartis Healthcare
4.1
Apex Laboratories
3.9
Agilent Technologies
4.1
Merck
4.3
Pfizer Products India
4.0
Boehringer-Ingelheim
3.9
Universal Corporation
3.6
MSD Pharmaceuticals
4.1
Contribute & help others!
You can choose to be anonymous
Companies Similar to Abbott
4.4
• 2k reviews
GlaxoSmithKline Pharmaceuticals
Biotech & Life sciences, Healthcare / Pharma, Manufacturing, Pharma
4.1
• 1.9k reviews
Pfizer
Manufacturing, Pharma
4.0
• 1.8k reviews
DIVI'S Laboratories
Pharma
3.7
• 1.4k reviews
Sanofi
Biotech & Life sciences, Manufacturing, Analytics & KPO, Pharma
4.2
• 1.2k reviews
Fresenius Kabi
Manufacturing, Analytics & KPO, Pharma
4.2
• 1k reviews
Piramal Pharma
Biotech & Life sciences, Pharma
4.0
• 1k reviews
Novo Nordisk
Internet, Pharma
4.1
• 976 reviews
Teva Pharmaceuticals
Healthcare / Pharma, Clinical Research, Pharma
3.9
• 1.2k reviews
AstraZeneca
Biotechnology, Pharma
4.1
• 848 reviews
Abbott FAQs
When was Abbott founded?
Abbott was founded in 1888. The company has been operating for 137 years primarily in the Pharma sector.
Where is the Abbott headquarters located?
Abbott is headquartered in Mumbai, Maharashtra. It operates in 5 cities such as Mumbai, New Delhi, Patna, Jaipur, Panchkula. To explore all the office locations, visit Abbott locations.
How many employees does Abbott have in India?
Abbott currently has more than 3,800+ employees in India. Marketing & Communication department appears to have the highest employee count in Abbott based on the number of reviews submitted on AmbitionBox.
Does Abbott have good work-life balance?
Abbott has a work-life balance rating of 4.0 out of 5 based on 3,100+ employee reviews on AmbitionBox. 79% employees rated Abbott 4 or above on work-life balance. This rating reflects the company's efforts to help employees maintain a healthy balance between their personal and professional lives. We encourage you to read Abbott work-life balance reviews for more details
Is Abbott good for career growth?
Career growth at Abbott is rated as moderate, with a promotions and appraisal rating of 3.3. 21% employees rated Abbott 3 or below, while 79% employees rated it 4 or above on promotions/appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading Abbott promotions/appraisals reviews for more detailed insights.
What are the pros and cons of working in Abbott?
Working at Abbott comes with several advantages and disadvantages. It is highly rated for company culture, salary & benefits and skill development. However, it is poorly rated for promotions / appraisal, based on 3,100+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
75 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
